SA
CL icon

Strategic Advocates’s Colgate-Palmolive CL Stock Holding History

Strategic Advocates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24
Closed -$2.05K – 265
2026
Q1 		$2.05K Sell
24
-1,775
-99% -$158K 0.01% 210
2025
Q4 		$143K Buy
1,799
+347
+24% +$27.2K 0.04% 136
2025
Q3 		$116K Buy
+1,452
New +$124K 0.03% 158

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Strategic Advocates's CL Position: Q2 2026 in Review

Strategic Advocates sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 24 shares — an estimated $2.05K sold.

Strategic Advocates first reported a position in CL in Q3 2025 and held it in 3 quarters. The position peaked at $143K in Q4 2025. 2,017 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Strategic Advocates reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
  • Strategic Advocates sold 24 Colgate-Palmolive shares in Q2 2026, an estimated $2.05K.
  • Strategic Advocates first reported a position in Colgate-Palmolive in Q3 2025 and held it in 3 quarters.
  • Strategic Advocates's Colgate-Palmolive position peaked at $143K in Q4 2025.
  • 2,017 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Strategic Advocates's 13F filing for Q2 2026, filed 13 Aug 2026.